Latest From Biotech Now

Warning: Don’t Let Bio-Euphoria Distract You from Being Disciplined


This piece by Allan L. Shaw was originally published in Life Science Leader. We currently in a period I call “bio-euphoria,” in which the biopharmaceutical industry is experiencing growth in almost every area from market performance to patient-focused legislation. In parallel to this positive momentum, there has also been a notable shift in management and operational strategy by Big Pharma companies in an attempt to keep evolving with the market. These companies are taking creative Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , ,

Discover Trends and Investment Opportunities at the BIO Investor Forum

hyde pier

The 2015 BIO Investor Forum in San Francisco is shaping up to be a must-attend event for private equity and public investors, research analysts, and industry executives focused on investment and business development opportunities in the life sciences. The Forum will include candid fireside chats between biopharma CEOs, analysts, and other industry experts. Come hear about recent company successes, what keeps the C-suite up at night, and where the industry’s leading companies are headed in 2016. Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

SAID Meeting on Sept 24 to Discuss Biotech Crop Approvals

Michael Froman

Agriculture in general and biotechnology in particular will be high on the agenda in meetings this week between U.S. and China officials, starting with an all-day session Thursday called the Strategic Agriculture Innovation Dialogue (SAID), according to AgriPulse. The SAID meeting, which isn’t open to the press or public, is supposed to focus on the big picture in technology, finance and innovation and will include discussion of the potential benefits of Big Data as well Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Wall Street Journal: The Assault on Drug Innovation


Today, the Wall Street Journal published an editorial commenting on yesterday’s proposed plan by Secretary Hillary Clinton’s campaign to dramatically increase intrusive government regulation of our industry. BIO shared many of the concerns raised by this editorial, concerns which were noted in our statement yesterday. To put into perspective the potential consequences of that proposal, the editorial noted as an example that “Inside of a decade or two, metastatic cancer may become a chronic condition and chemotherapy a relic.” Breakthroughs Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

China May Approve Several Biotech Crop Traits Sooner Than Later


According to Politico, the U.S. Chamber of Commerce says that China may announce the approval of seven biotech crop traits this week during a state visit by Chinese President Xi Jinping. The cotton, four soybean and two corn varieties that have been languishing in China’s approval process for up to four years…those seven traits are considered to be the likeliest candidates because they are in the final phase of the Chinese approval system. But what Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , ,